chartexchange

Lantheus Reports Third Quarter 2026 Financial Results

GlobeNewswire Inc. | Nov 5, 2026 7:00 AM EST

BEDFORD, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today reported financial results for its third quarter ended September 30, 2026.

Read original article